Pharmabiz
 

Healthpoint introduces 5x7 size of Oasis Ultra Tri-Layer Matrix

Fort Worth, TexasWednesday, November 7, 2012, 15:00 Hrs  [IST]

Healthpoint Biotherapeutics,a biopharmaceutical company focused on the development and commercialization of novel, cost-effective solutions for dermal repair and regeneration, has introduced a 5 cm x 7 cm size of OASIS Ultra Tri-Layer Matrix, a naturally-derived extracellular matrix (ECM) material formed from three layers of porcine small intestinal submucosa (SIS). The three-layer construct of ECM was designed to provide increased structure for difficult-to-heal and chronic wounds.

“The triple-layer SIS technology in OASIS Ultra has significantly changed the way I am able to take care of my patients. OASIS Ultra provides physicians with an easy- to-work-with material that features improved handling to facilitate placement and fixation, as well as increased structure and greater durability to minimize disruption to forming tissue,” noted Dr. Ally-Khan Somani, Assistant Professor and Director of Dermatologic Surgery and Cutaneous Oncology Division, Division of Dermatology, Indiana University School of Medicine. “The new 5x7 size is a welcome option for managing chronic wounds, particularly in outpatient sites of care.”

SIS, the base technology for OASIS Ultra, is among the most widely studied and published biomaterials, featured in more than 832 scientific publications.

“Since Healthpoint introduced the 7 cm x 10 cm and 7 cm x 20 cm sizes of OASIS Ultra 18 months ago, physicians have reported high levels of satisfaction with the technology’s improved handling on large wound types where products with increased strength and thickness are preferred,” commented Travis Baugh, president and chief operating officer of Healthpoint Biotherapeutics. “Building on this success, we are very pleased to introduce the 5x7 size of OASIS Ultra to bring the same benefits to the many clinicians treating smaller chronic wounds, especially in outpatient sites of care.”

OASIS Wound Matrix and OASIS Ultra are indicated for the management of surgical wounds, including donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, and wound dehiscence, partial- and full-thickness wounds, trauma wounds (including second-degree burns), venous ulcers, chronic vascular ulcers, diabetic ulcers, pressure ulcers, and draining wounds. These devices are derived from a porcine source and should not be used in patients with known sensitivity to porcine material. These devices are not indicated for use in third-degree burns.

 
[Close]